EOLS Q1 2025 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena

EOLSEvolus, Inc.

$353M

Q1 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$69M+15.5% YoY

Gross Profit

$47M68.1% margin

Operating Income

-$15M-22.1% margin

Net Income

-$19M-27.6% margin

EPS (Diluted)

$-0.30

QoQ Revenue Growth

-13.2%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$17M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$213M

Total Liabilities

$220M

Stockholders' Equity

-$7M

Cash & Equivalents

$68M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$69M	$59M	+15.5%
Gross Profit	$47M	$41M	+15.2%
Operating Income	-$15M	-$9M	-70.1%
Net Income	-$19M	-$13M	-44.1%

Revenue Segments

Product

$68M99%

Service

$448,0001%